首页> 外国专利> PANCREATIC LANGERHANS β CELL PROLIFERATION PROMOTER AND APOPTOSIS INHIBITOR, AND SCREENING OF CANDIDATE COMPOUNDS FOR THE E DRUGS

PANCREATIC LANGERHANS β CELL PROLIFERATION PROMOTER AND APOPTOSIS INHIBITOR, AND SCREENING OF CANDIDATE COMPOUNDS FOR THE E DRUGS

机译:胰腺Langerhansβ细胞增殖促进剂和细胞凋亡抑制剂,以及E药候选药物的筛选

摘要

It is indicated that the expression of Reg gene in ß cells can be remarkably induced and thus the proliferation of ß cells can be promoted by using an inflammation transmitter IL-6 together with glucocorticoid. It is also indicated that HGF inhibits apoptosis induced by Reg protein and that IL-6 and glucocorticoid induce the expression of HGF gene in cells. PARP inhibitors such as nicotinic acid amide and 3-aminobenzamide further enhance the induction of the expression of these genes. Moreover, the expression induction mechanism is analyzed by using the promoter regions of Reg gene and HGF gene and a method of efficiently screening candidate compounds for these gene expression inducers is developed.
机译:结果表明,通过将炎症递质IL-6与糖皮质激素一起使用,可以显着诱导Reg基因在ß细胞中的表达,从而可以促进ß细胞的增殖。还表明HGF抑制Reg蛋白诱导的凋亡,IL-6和糖皮质激素诱导HGF基因在细胞中表达。 PARP抑制剂(例如烟酰胺和3-氨基苯甲酰胺)进一步增强了这些基因表达的诱导。此外,利用Reg基因和HGF基因的启动子区分析了表达诱导机制,并开发了有效筛选这些基因表达诱导剂的候选化合物的方法。

著录项

  • 公开/公告号WO0193899A1

    专利类型

  • 公开/公告日2001-12-13

    原文格式PDF

  • 申请/专利权人 OKAMOTO HIROSHI;

    申请/专利号WO2001JP04660

  • 发明设计人 OKAMOTO HIROSHI;

    申请日2001-06-01

  • 分类号A61K38/20;A61K31/573;A61K38/22;A61K48/00;A61K45/00;A61K31/455;A61K31/165;A61P43/00;A61P3/10;G01N33/15;G01N33/50;C12Q1/02;

  • 国家 WO

  • 入库时间 2022-08-22 00:38:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号